INTERNATIONAL PATENT: ABLYNX NV FILES APPLICATION FOR "MULTISPECIFIC ANTIBODIES RECOGNISING HUMAN SERUM ALBUMIN, TCR AND A TUMOR ANTIGEN RECOGNISING MOIETY"

GENEVA, June 10 -- ABLYNX NV (Technologiepark 219052 Zwijnaarde) filed a patent application (PCT/EP2024/084075) for "MULTISPECIFIC ANTIBODIES RECOGNISING HUMAN SERUM ALBUMIN, TCR AND A TUMOR ANTIGEN RECOGNISING MOIETY" on Nov 29, 2024. With publication no. WO/2025/114529, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOUTTON, Carlo (c/o Ablynx N.V., Patent Department,Technologiepark 219052 Ghent-Zwijnaarde), DESCHAGHT, Pieter (c/o Ablynx N.V., Patent Department,Technologiepark 219052 Ghent-Zwijnaarde), FOUBERT, Ellen (c...